This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
As of today (2024-05-21), Zivo Bioscience's share price is $7.99. Zivo Bioscience's Median PS Value is $0.00. Therefore, Zivo Bioscience's Price to Median PS Value for today is 0.00.
The historical rank and industry rank for Zivo Bioscience's Median PS Value or its related term are showing as below:
ZIVO's Price-to-Median-PS-Value is not ranked *
in the Biotechnology industry.
Industry Median: 0.7 * Ranked among companies with meaningful Price-to-Median-PS-Value only.
Zivo Bioscience Median PS Value Historical Data
The historical data trend for Zivo Bioscience's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Zivo Bioscience's Median PS Value
For the Biotechnology subindustry, Zivo Bioscience's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zivo Bioscience's Price-to-Median-PS-Value Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Zivo Bioscience's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Zivo Bioscience's Price-to-Median-PS-Value falls into.
Zivo Bioscience Median PS Value Calculation
Zivo Bioscience's Median PS Value for today is calculated as
10-Year Median PS Ratio is 0.
Zivo Bioscience's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.029.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zivo Bioscience (OTCPK:ZIVO) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Zivo Bioscience's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
7.99
/
0.00
=
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zivo Bioscience Median PS Value Related Terms
Thank you for viewing the detailed overview of Zivo Bioscience's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Zivo Bioscience (Zivo Bioscience) Business Description
Zivo Bioscience Inc is a research and development company operating in both the biotech and agtech sectors, with an intellectual property portfolio comprised of proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. The company's pipeline candidates are; Bovine Mastitis, Canine Joint Health, Human Immune Modulation, Human Food Ingredients, and Skin Health.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ZIVO has been successfully added to your 